#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary immunodeficiency syndrome Allogenic stem cell transplantation Niemann-Pick disease Bile acid synthesis disorder Kearns-Sayre syndrome Myeloproliferative neoplasm Primary hyperoxaluria Retinal dystrophy Myelin oligodendrocyte glycoprotein antibody-associated disease Duchenne muscular dystrophy gene carrier Cardiomyopathy Arrhythmia Autologous haematopoietic stem cell transplant Cutaneous T-cell lymphoma stage I Squamous cell carcinoma of the vulva More trials…

    Learn about Rare Diseases

    Systemic sclerosis pulmonary – Basic Information Chordoma Inclusion body myositis – Trials in Disease Antisynthetase syndrome – Diagnostics Toxic epidermal necrolysis – Basic Information Retinitis pigmentosa – Basic Information Wiskott-Aldrich syndrome – Diagnostics Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Leukoencephalopathy – Life with Disease Activated PI3 kinase delta syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Levomethadone Hydrochloride Naproxen Sodium Filgrastim Tapentadol Hydrochloride AMODIAQUINE Digitoxin VALACICLOVIR HYDROCHLORIDE IDOR-1117-2520C Amiloride Hydrochloride 89ZR-CED88004S Obinutuzumab Deucrictibant Dupilumab Zopiclone Ipratropium Bromide Pasireotide Diaspartate Pamapimod Sodium 2-Hydroxylinoleate Dexamethasone Acetate Levobupivacaine Hydrochloride More therapies…

    Learn about Your Condition

    Malignant lymphoid neoplasm Hyperadrenocorticism Chordoma Large cell lung cancer stage 0 Atrophic vulvovaginitis Oedema peripheral Foetal growth restriction Myofascial pain syndrome Essential thrombocythaemia Antisynthetase syndrome Asthma Schizophreniform disorder End stage renal disease Cold type haemolytic anaemia Hypertrophic cardiomyopathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Sarcoma

  • Study of Pembrolizumab and Cabozantinib for Patients with Advanced Sarcomas: Undifferentiated Pleomorphic Sarcoma, Osteosarcoma, and Ewing Sarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant fibrous histiocytoma
    • Sarcoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cabozantinib
    • Pembrolizumab
    France

  • Study on Advanced Soft-Tissue Sarcoma: Testing Futibatinib and Drug Combination for Patients with Unresectable or Metastatic Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Ceritinib
    • Futibatinib
    • Glasdegib
    France

  • Study on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Pazopanib
    • Ipilimumab
    • Nivolumab
    France

  • Study of Atezolizumab Combined with Radiotherapy in Patients with Operable Soft Tissue Sarcomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Atezolizumab
    France
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!